These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28724282)

  • 1. Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer.
    Marchetti C; De Felice F; Di Pinto A; Romito A; Musella A; Palaia I; Monti M; Tombolin V; Muzii L; Benedetti Panici P
    Cancer Res Treat; 2018 Jul; 50(3):768-776. PubMed ID: 28724282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.
    Rose PG; Java J; Whitney CW; Stehman FB; Lanciano R; Thomas GM; DiSilvestro PA
    J Clin Oncol; 2015 Jul; 33(19):2136-42. PubMed ID: 25732170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma.
    Tian T; Gao X; Ju Y; Ding X; Ai Y
    Arch Gynecol Obstet; 2021 Mar; 303(3):793-801. PubMed ID: 33009996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.
    Mori T; Hosokawa K; Sawada M; Kuroboshi H; Tatsumi H; Koshiba H; Okubo T; Kitawaki J
    Int J Gynecol Cancer; 2010 May; 20(4):611-6. PubMed ID: 20686381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy.
    Ou Z; Zhao D; Li B; Wang Y; Liu S; Zhang Y
    Cancer Res Treat; 2021 Jan; 53(1):233-242. PubMed ID: 32972047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up.
    Luvero D; Plotti F; Aloisi A; Capriglione S; Ricciardi R; Miranda A; Lopez S; Scaletta G; De Luca G; Benedetti-Panici P; Angioli R
    Med Oncol; 2016 Oct; 33(10):110. PubMed ID: 27577931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.
    Angioli R; Plotti F; Montera R; Aloisi A; Luvero D; Capriglione S; Terranova C; De Cicco Nardone C; Muzii L; Benedetti-Panici P
    Gynecol Oncol; 2012 Nov; 127(2):290-6. PubMed ID: 22819938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of primary radical hysterectomy and neoadjuvant chemotherapy followed by radical hysterectomy in Stage IB2, IIA bulky cervical cancer.
    Musaev A; Guzel AB; Khatib G; Gulec UK; Vardar MA; Altintas A; Gumurdulu D
    Eur J Gynaecol Oncol; 2015; 36(5):579-84. PubMed ID: 26513887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute "Prof. Dr. Ion Chiricuta" experience.
    Marita A; Ordeanu C; Rancea A; Nicolae T; Nagy VM
    J Med Life; 2018; 11(1):42-50. PubMed ID: 29696064
    [No Abstract]   [Full Text] [Related]  

  • 11. Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients.
    Fu B; Wei L; Wang C; Xiong B; Bo J; Jiang X; Zhang Y; Jia H; Dong J
    J Xray Sci Technol; 2024; 32(2):427-441. PubMed ID: 38189735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation.
    Sun Y; Li G; Hai P; Cao Y; Han P; Liu Y; Wen J; Wang Y; Cheng X; Ren F
    World J Surg Oncol; 2022 Dec; 20(1):389. PubMed ID: 36476481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study).
    Gadducci A; Sartori E; Maggino T; Zola P; Cosio S; Zizioli V; Lapresa M; Piovano E; Landoni F
    Gynecol Oncol; 2013 Dec; 131(3):640-4. PubMed ID: 24096111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram Predicting Overall Survival in Patients With Locally Advanced Cervical Cancer Treated With Radiochemotherapy Including Image-Guided Brachytherapy: A Retro-EMBRACE Study.
    Sturdza AE; Pötter R; Kossmeier M; Kirchheiner K; Mahantshetty U; Haie-Meder C; Lindegaard JC; Jurgenliemk-Schulz I; Tan LT; Hoskin P; van Limbergen E; Gillham C; Segedin B; Tharavichitkul E; Iturre EV; Fokdal LU; Polterauer S; Kirisits C; Tanderup K
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):168-177. PubMed ID: 33932530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
    Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
    J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer.
    Benedetti-Panici P; Greggi S; Scambia G; Amoroso M; Salerno MG; Maneschi F; Cutillo G; Paratore MP; Scorpiglione N; Mancuso S
    Eur J Cancer; 1998 Feb; 34(3):341-6. PubMed ID: 9640219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.